Form 8-K - Current report:
SEC Accession No. 0000950170-23-024879
Filing Date
2023-05-30
Accepted
2023-05-30 16:30:56
Documents
13
Period of Report
2023-05-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20230525.htm   iXBRL 8-K 108822
2 EX-10.1 asmb-ex10_1.htm EX-10.1 8485
  Complete submission text file 0000950170-23-024879.txt   244414

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asmb-20230525_lab.xml EX-101.LAB 17563
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asmb-20230525.xsd EX-101.SCH 2483
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asmb-20230525_pre.xml EX-101.PRE 11116
7 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20230525_htm.xml XML 4546
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 23976939
SIC: 2834 Pharmaceutical Preparations